biological source
Saccharomyces cerevisiae
Quality Level
assay
≥98.5% (HPLC)
form
powder
optical activity
[α]/D 174 to 182 °, c = 1.0% (w/v) in water
technique(s)
HPLC: suitable, cryopreservation: suitable
mp
97-99 °C
application(s)
agriculture
cell analysis
genomic analysis
life science and biopharma
SMILES string
[H]O[H].[H]O[H].OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
InChI
1S/C12H22O11.2H2O/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12;;/h3-20H,1-2H2;2*1H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-;;/m1../s1
InChI key
DPVHGFAJLZWDOC-PVXXTIHASA-N
General description
D-(+)-海藻糖是一种二糖,作为化学伴侣并作为微生物中的碳水化合物储备。它起到渗透调节剂的作用,保护细胞免受各种环境压力的影响。此外,它还在冷冻干燥过程中的蛋白质稳定性方面发挥着至关重要的作用,使其成为生化、细胞培养和赋形剂研究领域的宝贵资产
Application
- 在各种细胞冷冻介质中用作冷冻保护剂
- 用于赋形剂研究
Biochem/physiol Actions
海藻糖是一种由两个葡萄糖单位通过1-1α键结合而形成的非还原性糖。它被认为可为植物和动物提供承受缺水阶段的能力。
Features and Benefits
- 由酿酒酵母制备
- 适用于 HPLC 和 GC-MS(4)
Preparation Note
由Payen, R., Can的修改过程而制备。J. Res., 27B, 749 (1949).
Still not finding the right product?
Explore all of our products under D-(+)-海藻糖 二水合物
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
Sandra Jesus et al.
AAPS PharmSciTech, 19(1), 101-113 (2017-06-15)
This report extensively explores the benefits of including chitosan into poly-ε-caprolactone (PCL) nanoparticles (NPs) to obtain an improved protein/antigen delivery system. Blend NPs (PCL/chitosan NPs) showed improved protein adsorption efficacy (84%) in low shear stress and aqueous environment, suggesting that
Sabine Ullrich et al.
Journal of pharmaceutical sciences, 104(6), 2040-2046 (2015-04-03)
The importance of cake adhesion to the inside vial wall during lyophilization of amorphous trehalose cakes was determined by using hydrophobized vials. The degrees of cake shrinkage and cracking were determined independently by photographic imaging of the cake top surface
Alan Twomey et al.
International journal of pharmaceutics, 487(1-2), 91-100 (2015-04-19)
In frozen and lyophilized systems, the biological to be stabilized (e.g. therapeutic protein, biomarker, drug-delivery vesicle) and the cryo-/lyo-protectant should be co-localized for successful stabilization. During freezing and drying, many factors cause physical separation of the biological from the cryo-/lyo-protectant
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| T5251-100G | 04061837347276 |
| T5251-25G | 04061837347306 |
| T5251-10G | 04061837347283 |
| T5251-250G | 04061837347290 |